World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
18425
World Ranking
2573
National Ranking
1228

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Richard T. D'Aquila is affiliated with Northwestern University in the United States, focusing predominantly on medical research. Their work spans multiple areas within medicine, with a significant emphasis on infectious diseases, immunology, and virology.

The scientist's main fields of study include:

  • Medicine

Within medicine, their research is concentrated on subfields such as:

  • Infectious Diseases
  • Immunology
  • Virology
  • Cardiology and Cardiovascular Medicine
  • General Health Professions

D'Aquila's main research topics cover:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 detection and testing
  • HIV-related health complications and treatments
  • COVID-19 epidemiological studies

Their recent scholarly outputs include the following publications:

  • Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals, 2021, EClinicalMedicine
  • High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay, 2020, PLoS ONE
  • mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport, 2020, Cell Reports
  • Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, 2020, Research Square (Research Square)
  • COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men, 2021, The Journal of Infectious Diseases

D'Aquila has published extensively in various venues, with frequent publications occurring in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • AIDS Research and Human Retroviruses
  • Translational Research
  • Open Forum Infectious Diseases

The scientist collaborates with a number of colleagues, including:

  • Brian Mustanski
  • Thomas W. McDade
  • Alexis R. Demonbreun
  • Elizabeth M. McNally
  • Daniel T. Ryan

Among recognitions, Richard T. D'Aquila is a member of the Association of American Physicians.

Best Publications

  • Immune control of HIV-1 after early treatment of acute infection

    Eric S. Rosenberg;Marcus Altfeld;Samuel H. Poon;Mary N. Phillips

  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

    Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

    Javier Martinez-Picado;Anu V. Savara;Lorraine Sutton;Richard T. D’Aquila

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

    A J Japour;D L Mayers;V A Johnson;D R Kuritzkes

  • The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

    Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder

  • Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection

    Susan J. Little;Eric S. Daar;Richard T. D'Aquila;Philip H. Keiser

  • Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    Richard T. D'Aquila;Michael D. Hughes;Victoria A. Johnson;Margaret A. Fischl

  • Drug Resistance Mutations in HIV-1.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy

    Richard T. D'Aquila;Victoria A. Johnson;Seth L. Welles;Anthony J. Japour

  • Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response

    Michael D. Hughes;Victoria A. Johnson;Martin S. Hirsch;James W. Bremer

  • Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

    Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  • Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

    Lee Bacheler;Susan Jeffrey;George Hanna;Richard D'Aquila

  • Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study

    David W. Haas;Laura M. Smeaton;Robert W. Shafer;Gregory K. Robbins

  • Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Robert W. Shafer;Laura M. Smeaton;Gregory K. Robbins;Victor De Gruttola

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Antiretroviral resistance during successful therapy of HIV type 1 infection

    J. Martinez-Picado;M. P. DePasquale;N. Kartsonis;G. J. Hanna

  • HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy

    Monika Hermankova;Stuart C. Ray;Christian Ruff;Monique Powell-Davis

  • Reduced antiretroviral drug susceptibility among patients with primary HIV infection, JAMA 282: 1142-9

    Susan J. Little;E. S. Daar;R. T. D'Aquila;P. H. Keiser

Frequent Co-Authors

Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Brian Mustanski
Brian Mustanski Northwestern University
Bruce D. Walker
Bruce D. Walker Harvard University
Javier Martinez-Picado
Javier Martinez-Picado University of Vic - Central University of Catalonia
Elizabeth M. McNally
Elizabeth M. McNally Northwestern University
Roy M. Gulick
Roy M. Gulick Cornell University
Scott M. Hammer
Scott M. Hammer Columbia University
Angela M. Caliendo
Angela M. Caliendo Brown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related healthcare degrees can open diverse career opportunities. Nursing fields such as becoming a Nurse Practitioner often complement immunology knowledge, especially for advanced clinical roles.

When exploring educational options, students might look for the which nurse practitioner program is easiest to balance with other commitments. However, ease should be weighed alongside program quality and outcomes.

For those focusing on mental health and immunology interplay, the best psychiatric mental health nurse practitioner programs online offer strong clinical placement rates, which are crucial for gaining hands-on experience.

Cost is another important factor. Prospective students can find the cheapest online pmhnp programs that provide quality education without excessive financial burden.

After obtaining degrees such as a Doctor of Nursing Practice (DNP), graduates should research earning potential, which varies by location. Reviewing a dnp salary by state can help in making informed career and relocation decisions.

Best Scientists Citing Richard T. D'Aquila

Trending Scientists